Letter: Teratogenic effects of combination chemotherapy.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D005532:Foot Deformities, Congenital; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008431:Maternal-Fetal Exchange; D009588:Nitrogen Mustard Compounds / Q000009:adverse effects; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011344:Procarbazine / Q000009:adverse effects; D014747:Vinblastine / Q000009:adverse effects
D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D011344:Procarbazine; D014747:Vinblastine